Hemophilia B gene therapy represents a groundbreaking advancement in the treatment landscape for individuals suffering from this genetic disorder.With the recent approval of Hemgenix by the FDA, patients like Terence Blue are experiencing transformative outcomes, escaping the relentless cycle of clotting factor replacement therapies.